Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

580 V. TREATMENTS FOR ADDICTIONSrisks for relapse, and promising approaches for relapse prevention. Int J Addict, 25,1085–1140.Christie, K. A., Burke, J. D., Regier, D. A., Rae, D. S., Boyd, J. H., & Locke, B. Z.(1988). Epidemiologic evidence for early onset of mental disorders and higher riskof drug abuse in young adults. Am J Psychiatry, 145, 971–975.Clark, D. B., Bukstein, O. G., Smith, M. G., Kaczynski, N. A., Mezzich, A. C., & Donovan,J. E. (1995). Identifying anxiety disorders in adolescents hospitalized for alcoholabuse or dependence. Psychiatr Serv, 46, 618–620.Clark, D. B., & Sayette, M. A. (1993). Anxiety and the development of alcoholism. AmJ Addict, 2, 56–76.Cloninger, C. R., Bohman, M., & Sigvardsson, S. (1981). Inheritance of alcohol abuse.Arch Gen Psychiatry, 38, 861–871.Coate, D., & Grossman, N. (1987, Fall). Change in alcoholic beverage prices and legaldrinking age. Alcohol Health Res World, pp. 22–25.Coetzee, M., Kaminer, Y., & Morales, A. (2002). Megadose intranasal methylphenidate(Ritalin) abuse in adult with attention deficit hyperactivity disorder. Subst Abuse,23, 165–169.Cole, E. J. (1997). New developments in biological measures of drug prevalence. In L.Harrison & A. Hughes (Eds.), Validity of self-reported drug use: Improving the accuracyof survey estimates (NIDA Research Mongraph 167, pp. 108–130). Rockville,MD: National Institute on Drug Abuse.Corby, E. A., Roll, J. M., & Ledgerwood, D. M. (2000). Contingency managementinterventions for treating the substance abuse of adolescents: A feasibility study.Exp Clin Psychopharmacol, 8, 371–376.Cornelius, J. R., Bukstein, O. G., Birmaher, B., Salloum, I. M., Lynch, K., Pollock, N.K., et al. (2001). Fluoxetine in adolescents with major depression and an alcoholuse disorder: An open label trial. Addict Behav, 26, 735–739.Cornelius, J. R., Salloum, I. M., Cornelius, M. D., Perel, J. M., Thase, M. E., Ehler, J. G.,& Marm, J. (1993). Fluoxetine trial in suicidal depressed alcoholics. PsychopharmacolBull, 29, 195–199.Costello, J. E., Angold, A., Burns, B. J., Stangl, D. K., Tweed, D. L., Erkanli, A., &Wotrthman, C. M. (1996). The Smoky Mountains study of youth: Goals, design,methods, and the prevalence of DSM-II-R disorders. Arch Gen Psychiatry, 53,1129–1136.Crumley, F. E. (1990). Substance abuse and adolescent suicidal behavior. JAMA, 263,3051–3056.Deas, D., & Thomas, S. E. (2001). An overview of controlled studies of adolescent substanceabuse treatment. Am J Addict, 10, 178–189.DeMilio, L. (1989). Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry,146, 1212–1214.Dennis, M. L., Godley, S. H., Diamond, G., Tims, F., Babor, T., Donaldson, J., et al.(2004). Main findings of the Cannabis Youth Treatment randomized field experiment.J Subst Abuse Treat, 27, 197–213.Dennis, M. L., Titus, J. C., White, M., Unsicker, J., & Hodgkins, D. (2003). GlobalAppraisal of Individual Needs (GAIN): Administration guide for the GAIN and relatedmeasures (5th ed.). Bloomington, IL: Chestnut Health Systems.